Artificial heart maker Picard Medical seeks U.S. IPO
Picard Medical (PMI), the developer of the SynCardia artificial heart, disclosed this week its plans to seek a public listing ...
Business Insider14d
Clearmind Medicine’s FDA-Approved Clinical Trial for CMND-100 Moves Forward as Drug Arrives in the U.S., Advancing Toward Key Milestones
This marks a key milestone as the Company prepares to initiate its FDA-approved Phase I/IIa clinical trial for the ... Shares of Clearmind are listed for trading on Nasdaq under the symbol "CMND" and ...
Nasdaq15d
FDA Approves Novartis' Oral Fabhalta For Treatment Of Adults With Complement 3 Glomerulopathy
Regulatory reviews for this indication are ongoing in China and Japan. Fabhalta received its first FDA approval in December 2023 for the treatment of adults with paroxysmal nocturnal ...